Overdiagnosis of invasive breast cancer and DCIS: Why do estimates vary?

Breast Diseases

Volumn 25, Issue 3, 2014, Pages 196-201

  Feig, Stephen A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; CAUSE OF DEATH; DIAGNOSTIC ERROR; ENVIRONMENTAL FACTOR; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL RATE; SWEDEN; TREND STUDY;

EID: 84908094682     PISSN: 1043321X     EISSN: 18781918     Source Type: Journal    
DOI: 10.1016/j.breastdis.2014.07.041     Document Type: Article

References (31)

1. H. Seidman, S.K. Gelb, E. Silverberg, N. LaVerda, and J.A. Lubera Survival experience in the Breast Cancer Detection Demonstration Project CA Cancer J Clin 37 1987 258 290
2. L. Tabár, B. Vitak, and T.H. Chen Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades Radiology 260 2011 658 663
3. A.M. Yen, S.W. Duffy, and T.H.-H. Chen Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening Cancer 118 2012 5728 5732
4. D. Puliti, S.W. Duffy, and G. Miccinesi EUROSCREEN Working Group Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review J Med Screen 19 2012 42 56
5. R. de Gelder, E.A. Heijnsdijk, N.T. van Ravesteyn, J. Fracheboud, G. Draisma, and H.J. de Koning Interpreting overdiagnosis estimates in population-based mammography screening Epidemiol Rev 33 2011 111 121
6. D. Puliti, M. Zappa, G. Miccinesi, P. Falini, E. Crocetti, and E. Paci An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence Eur J Cancer 45 2009 3166 3171
7. E. Paci, G. Miccinesi, and D. Puliti Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy Breast Cancer Res 8 2006 R68
8. A.H. Olsen, O.F. Agbaje, J.P. Myles, E. Lynge, and S.W. Duffy Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program Breast J 12 2006 338 342
9. M. Waller, S. Moss, J. Watson, and H. Møller The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales Cancer Epidemiol Biomarkers Prev 16 2007 2257 2261
10. S.W. Duffy, L. Tabar, and A.H. Olsen Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England J Med Screen 17 2010 25 30
11. L. Tabár, G. Fagerberg, S.W. Duffy, N.E. Day, A. Gad, and O. Gröntoft Update of the Swedish two-county program of mammographic screening for breast cancer Radiol Clin North Am 30 1992 187 210
12. S.W. Duffy, and D. Parmar Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time Breast Cancer Res 15 2013 R41
13. A. Bleyer, and H.G. Welch Effect of three decades of screening mammography on breast-cancer incidence N Engl J Med 367 2012 1998 2005
14. L. Garfinkel, C.C. Boring, and C.W. Heath Jr. Changing trends: an overview of breast cancer incidence and mortality Cancer 74 1994 222 227
15. D.B. Kopans Point: the New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically incorrect and should be withdrawn J Am Coll Radiol 10 2013 317 319
16. L. Esserman, Y. Shieh, and I. Thompson Rethinking screening for breast cancer and prostate cancer JAMA 302 2009 1685 1692
17. M. Broeders, S. Moss, and L. Nyström EUROSCREEN Working Group The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies J Med Screen 19 2012 14 25
18. S.A. Feig Ductal carcinoma in situ. Implications for screening mammography Radiol Clin North Am 38 2000 653 668
19. M.J. Silverstein Noninvasive breast cancer. The dilemma of the 1990s Obstet Gynecol Clin North Am 21 1994 639 658
20. C.R. Smart, C. Byrne, and R.A. Smith Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project CA Cancer J Clin 47 1997 134 149
21. L. Tabár, S.W. Duffy, B. Vitak, H.H. Chen, and T.C. Prevost The natural history of breast carcinoma: what have we learned from screening? Cancer 86 1999 449 462
22. M.D. Lagios, F.R. Margolin, P.R. Westdahl, and M.R. Rose Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence Cancer 63 1989 618 624
23. G.F. Schwartz, G.C. Finkel, J.C. Garcia, and A.S. Patchefsky Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone Cancer 70 1992 2468 2474
24. M.J. Silverstein, J.R. Waisman, and P. Gamagami Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice Cancer 66 1990 102 108
25. M.F. Yen, L. Tabár, B. Vitak, R.A. Smith, H.H. Chen, and S.W. Duffy Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening Eur J Cancer 39 2003 1746 1754
26. United Kingdom National Health Service. NHS Breast Screening Programme & Association of Breast Surgery at BASO: an audit of screen detected breast cancers for the year of screening April 2007 to March 2008. UK West Midlands Cancer Intelligence Unit; 2009.
27. M.J. Silverstein, D.N. Poller, and J.R. Waisman Prognostic classification of breast ductal carcinoma-in-situ Lancet 345 1995 1154 1157
28. J. McCann, P. Treasure, and S. Duffy Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme J Med Screen 11 2004 117 125
29. R.A. Smith, D. Saslow, and K.A. Sawyer American Cancer Society guidelines for breast cancer screening: update 2003 CA Cancer J Clin 53 2003 141 169
30. S.J. Katz, and M. Morrow Addressing overtreatment in breast cancer: The doctors' dilemma Cancer 119 2013 3584 3588
31. S. Masood Focusing on breast cancer overdiagnosis and overtreatment: the promise of molecular medicine Breast J 19 2013 127 129